 |
 |
|
Bio-Buzz No.2 / 2006
HEADLINE NEWS
Rob Hockney, AstraZeneca - Overview of AstraZeneca’s route to market and in-licensing programme with question time 11.00 SW talk session 1 10 minute presentations up to 5 minute question and answer time
12.30 Lunch and Networking 13.20 SW talks session 2 10 minute presentations up to 5 minute question and answer time
14.50 Closing statements from Chair and Host Tea and Networking16.00 Close Chair: Rob Hockney, Director of Global Collaborations and Licenses, Discovery Alliances, AstraZenecaHost: Gugs Lushai T: 0117 9008250 E: gugs.lushai@bioapproaches.co.ukContact: Jade Fullbrook-Smith T: 0117 9008250 E: jade.fullbrook-smith@greatwesternenterprise.co.uk
UPDATE BioApproaches SW – Knowledge Management Service Access to analyst reports, market research, drug pipeline information, patent data, M&A updates, and industry news. Among other things, this helps SMEs to find potential partners, and build business plans for partnerships and funding.... For market intelligence Contact: Gugs Lushai T: 0117 9008250 E: gugs.lushai@bioapproaches.co.uk New Biomarkers One of the big ideas that emerged since the completion of the human genome project involves new biomarkers and tests used for tailoring new drugs that match an individual’s genetic makeup. The Biomarkers & Related Tests for Molecular Diagnostics & Pharma / Biotech R&D report is about the market for genomic, metabolomic and protein biomarkers and the related tests. The tests are used as molecular diagnostics and as pharmacogenomic assays to measure drug safety or effectiveness… For more information Contact: Gugs Lushai T: 0117 9008250 E: gugs.lushai@bioapproaches.co.uk Tissue Regeneration technologies Markets & commercial opportunities held this February, 2006 (jointly sponsored by BioApproaches SW) Focus: Leading edge discoveries and advancements in tissue repair and regeneration technologies were featured in this successful meeting hosting around one hundred guests including many of the top specialists in the field. For contact referrals and feedback please Contact: Oonagh Kelleher E: O.Kelleher@bath.ac.uk
INDUSTRY CORNER Recruitment - The following specialists are available in the SW for employment: Analytical Chemist Analytical Technician Compound Coordinator Database Manager Database Support Assistant Group Leader (High Throughput Chemistry) High Throughput Chemist High Throughput Technician HR Manager Purification Technician Research Chemist Scale Up Chemist Scientific Assistant (Compound Handling) Scientific Assistant (HTC) Scientific Assistant (Laboratory Support) Scientific Assistant (Purification) Scientific Assistant (Scale Up) Contact: Louise Cantrill E. Louise.Cantrill@e-penna.com Biopharmaceutical Healthcare Marketing Executive - bioProcessUK is a Knowledge Transfer Network dedicated to advancing the UK biopharmaceutical bioprocessing sector and is managed by the BioIndustry Association (www.bioindustry.org). As part of its programme to broaden the business experience of graduates, bioProcessUK has a vacancy for a recent bioscience graduate/PhD student with an interest in biopharmaceuticals / bioprocessing. This entry level marketing role is for a fixed term of 12 months, and is based in London. The role embraces market research, events and promotional activities and will suit a new (post)graduate who is a team player, has an excellent attitude and an interest in contributing towards promoting the healthcare benefits of biopharmaceuticals. Candidates can email their CV to bioProcessUK@bioindustry.org - The closing date is 9th March 2006. Courses…CPD…Courses IBC Biopharmaceutical Spring School 5-7 April 2006 Three-day residential Spring School on the European biopharmaceutical industry from lab to market, Fitzwilliam College, Cambridge. Ask BioApproaches SW for discount details and see www.bioindustry.org/biodocuments/bioprocessuk/IBC_Spring_School_2006.pdf cGMP For Quality Assurance and Quality Control of Pharmaceuticals, Biopharmaceuticals and Biologics 3 - 5 April, 2006 - The Burlington Hotel, Dublin, Ireland COURSE LIMITED TO 20 ATTENDEES! For details see www.cfpie.comFunds…Funding…Funds Mission to Beijing - March 2006 A travel grant of £750 is still available to UK SMEs interested in joining a group to Beijing from 26th-30th March. Places are going quickly so please register your interest ASAP with Sam on samantha.bruce@emtechna.net to receive application forms. Please note that non SMEs are of course welcome to join the trade mission. Catalyst Venture Partners announces "Zero-to-Hero 2006" 'Zero to Hero' for technology innovators, 20 selected companies will gain a place on a one-day fast-track investment event, to be held at the Williams Formula 1 Conference Centre in Oxfordshire, where they will have the opportunity to interactively evaluate their business plans with five leading venture capital companies. The "Zero-to-Hero" event, which is being run in conjunction with Business XL and NESTA, is being sponsored by: the Royal Bank of Scotland, TLT solicitors, innovation incubators SETsquared (a collaboration between the Universities of Bath, Bristol, Southampton and Surrey) and the venture capital fund Eden Ventures. The event is open to all early-stage technology companies. To enter, companies need to send an Executive Summary of their business plan by Monday 6 March 2006 to: Zero-to-Hero, Catalyst Venture Partners Ltd, 2 Queens Parade, Bath, BA1 2NJ or email it to: zerotohero@catvp.com. For further details, see Catalyst's website www.catvp.com/zerotohero. News… News… News - Three Wiltshire organisations have won a share in a £25m government fund to turn research carried out in the public sector into commercial success. NHS Innovations South West in Salisbury gets £995,000 for a project to make NHS research easier to sell. PPARC in Swindon will receive £893,000 to transfer information from three international research organisations. An MoD laboratory will get £450,000 to create license deals and investment opportunities in defence technology. Deals created by Ploughshare Innovations Ltd, the Defence Science and Technology Laboratory (Dstl) at Porton Down, will cover a range of areas from telecommunications to diagnostics throughout the UK. The projects have been awarded the cash from the Department of Trade and Industry to market their work. - Pennsylvania Gov: $500M for Bioscience Research Initiative Since passage of Act 77 in 2001, the Pennsylvania Department of Health (PDEH) has used 19 percent of the state's tobacco settlement funds to fund biomedical-related research projects through the Commonwealth Universal Research Enhancement (CURE) program. The program provides formula and competitive grants to universities to support research priorities set by PDEH. Gov. Rendell is proposing that the Commonwealth borrow $500 million to finance a new bioscience research initiative named after the late Pittsburgh scientist, Dr. Jonas Salk. The governor proposes to maintain half of CURE's funding level, but use the other half - or just under 10 percent of the state's share of tobacco settlement funds - to repay the bonds. The move is expected to provide greater flexibility in the use of the funds and hasten any economic development opportunities resulting from commercialisation of research results. If the request is approved by the legislature, the Salk Legacy Fund would provide dollar-for-dollar matching grants to the state's leading bioscience researchers in academia and industry. The fund would be administered by the Jonas Salk Legacy Fund board, to be comprised of university, medical research, bioscience, and public agency representatives. Nearly $100 million of the $500 million pool would be used in "starter kits" to help academic medical centers, research colleges, and universities buy the necessary tools and machines to conduct investigations and experiments. The remaining $400 million would be used for grants and awarded to companies and institutions planning to build laboratories and incubators. More information is available at: http://www.state.pa.us/papower/cwp/view.asp?A=11&Q=449550 Partnering opportunity…. Business opportunity - Bioventures.co.uk has been developed to assist regional networking between universities, companies and investors and the promotion of early-stage business opportunities in the healthcare, biomedical and bioscience fields, for which investment, licensing or partnering is sought. Contact. Website : John Bates Ph.D, Bioventures.co.uk jbates@bioventures.co.uk http://www.bioventures.co.uk - Evolution Life Science works closely with universities, undertaking IP auditing, technology evaluation and market due diligence to ensure the creation of successful spinouts and high value licensing deals. Operating at the interface higher education and industry, Evolution is uniquely positioned to facilitate cross-fertilisation and collaboration. Based on our extensive knowledge of academia and commercial imperatives, Evolution facilitates the optimal alignment of university and industry needs. Contact Dr Jason Beckwith at j.beckwith@evolutionlifescience.com or on +44 (0)1355 272245 - Wood, Ngo and Eisenberg LLP - Patent and trademark services in the United States. We are a United States Intellectual Property Law Firm located next to the U.S. Patent and Trademark Office (USPTO) in Alexandria, Virginia. Our patent attorneys have years of experience drafting patent applications and our prices are generally well below the fees charged by larger law firms. For further information contact: Gugs Lushai T: 0117 9008250 E: gugs.lushai@bioapproaches.co.uk - Technomark Consulting is an innovative, specialist consultancy group, dedicated to offering customised responses to the needs of our clients (pharmaceutical and biotechnology companies, CROs, CPMs, investment banks and public sector organisations). We field a team of industry-experienced individuals who undertake assignments in the following areas: Drug Development; Outsourcing; (Manufacturing and R&D); Strategic Marketing; Techno-Commercial Due Diligence; Strategic Planning; Competitive Intelligence; In-house Training. Contact:: Mr Gérard Moxon T: 020 7229 9239 E: gmoxon@technomark.com - Network for Senior Executives in Pharmaceuticals and Biotechnology Networking Evening: Wednesday 8 March 2006, 6.00pm, Four Seasons Hotel, London. This event is an opportunity for high-level executives to hear short talks and participate in a panel discussion with high profile individuals in the industry, and to network with key players from pharma, biotech and the investment sector. Speakers: Lord Sainsbury of Turville; Percy Lomax - Executive Chairman, ReGen Therapeutics; Michael Ashton - Chief Executive Officer, SkyePharma. For further information and to register, go to www.nsep.org or call NSEP on 01923 256585 - MerseyBio invite you to join the esymbio portal. This is an interactive web portal set up to provide a 'one-stop-shop' to facilitate collaboration within the life sciences, including information retrieval and sharing, partner identification and online collaboration (meeting rooms and discussion forums, and online presentation facilities). You can register by going to www.esymbio.com - ‘Using NERC Science’ (UNS) was created specifically to inform people who are interested in how NERC Science is used. Under headings including "Knowledge Transfer Opportunities", "Science- into-Policy" and "Research Programme News" we cover news such as KT funding opportunities, commercial spin-offs, science-into-policy activities and science highlights. We also publicise consultations (seeking your views) and events of possible interest to stakeholders. If you wish to receive ‘Using NERC Science’ on a regular basis, please go to our website and register online at http://www.nerc.ac.uk/using/reg_form.shtml
EVENTS - 3 month forecast in chronological order...
Contact Us For further information on any of these items, please visit our website: www.bioapproaches.co.uk or contact us directly.
|
|
